Cloning and characterization of the proximal murine Phex promoter

Endocrinology

Volumn 142, Issue 9, 2001, Pages 3987-3995

  Liu, Shiguang ^a   Guo, Rong ^a   Quarles, L Darryl ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CIS ACTING ELEMENT; DIFFERENTIATION INDUCING FACTOR; LUCIFERASE; PARATHYROID HORMONE; PHOSPHATE; PROTEINASE;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CONSENSUS SEQUENCE; GENE DELETION; GENETIC TRANSCRIPTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TATA BOX;

EID: 0034878896     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.9.8403     Document Type: Article

References (47)

1. A gene (Pex) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets
2. The pathophysiology of XLH, ADH, and TOM: A perPHEXing problem
3. Cloning and sequencing of human Pex from a bone cDNA library: Evidence for its developmental stage-specific regulation in osteoblasts
4. Phex expression in parathyroid gland and parathyroid hormone dysregulation in x-linked hypophosphatemia
5. Pex/Pex tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice
6. Cloning of human Pex cDNA: Expression, subcellular localization, and endopeptidase activity
7. X-linked hypophosphatemic rickets and the murine Hyp homologue
8. Cross transplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect
9. Phosphate transport in immortalized cell cultures from the renal proximal tubule of normal and Hyp mice: Evidence that the Hyp gene locus product is an extrarenal factor
10. Intrinsic mineralization defect in Hyp mouse osteoblasts
11. Defective bone formation by Hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect
12. The effects of bone marrow transplantation on X-linked hypophosphatemic mice
13. In vitro and in vivo down regulation of osteoblastic Phex expression by PTH
14. mRNA expression of Phex in mice and rats: The effect of low phosphate diet
15. Cartilage abnormalities are associated with abnormal Phex expression and altered matrix protein and MMP-9 expression in Hyp mice
16. Genomic organization of the human Pex gene mutated in X-linked dominant hypophosphatemic rickets
17. The transcription factor sox9 is involved in BMP-2 signaling
18. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: Minimal role of the proximal E-box cis-acting promoter elements
19. A distinct cation-sensing mechanism in MC3T3-E1 osteoblasts functionally related to the calcium receptor
20. Effects of dexamethasone and vitamin D3 on cartilage differentiation in a clonal chondrogenic cell population
21. SOX9 is a potent activator of the chondrocyte-specific enhance of the proα1(II) collagen gene
22. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells
23. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription
24. Sex-reversing mutations affect the architecture of SRY-DNA complexes
25. DNA-binding specificity of GATA family transcription factors
26. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro
27. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: Two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core
28. The DNA-binding specificity of SOX9 and other SOX proteins
29. B lineage-specific interactions of an immunoglobulin enhancer with cellular factors in vivo
30. The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation
31. Transcription factor AP-4 participates in activation of bovine leukemia virus long terminal repeat by p34 Tax
32. A survey of 178 NF-Y binding CCAAT boxes
33. A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro
34. Selection of optimal κB/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation
35. The LIM-only protein LMO2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and LDB1/NLI proteins
36. Identification of novel DNA binding targets and regulatory domains of a murine tinman homeodomain factor, NKX-2.5
37. Formation of a monomeric DNA binding domain by Skn-1 bZIP and homeodomain elements
38. DNA-binding specificity of GATA family transcription factors
39. Core promoter of the mouse myelin basic protein gene governs brain-specific transcription in vitro
40. Identification of AML-1 and the 8;21 translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: The runt homology domain is required for DNA binding and protein-protein interactions
41. Molecular cloning of the murine Phex gene promoter (1)
42. 1,25-(OH)2D3 down-regulates expression of Phex, a marker of the mature osteoblast
43. A male-specific role for SOX9 in vertebrate sex determination
44. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
45. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites
46. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene
47. A composite intragenic silencer domain exhibits negative and positive transcriptional control of the bone-specific osteocalcin gene: Promoter and cell type requirements